Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
CLOPIDOGREL ARENA 75 mg
Antiplatelet agent indicated in the prevention of cardiovascular events (myocardial infarction, stroke)
Active Substance (INN)
CLOPIDOGRELUM
Packaging
1,2,4,12 bl x 7 tabs; 1,3,9,10 bl x 10 tabs
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.